Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18+
SponsorMedical University of South Carolina
About this trial
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.
Eligibility criteria
Qualifiers
Adult subjects at least 18 years of age.
Subjects presenting with squamous cell carcinoma of mucosal origin and are at risk for recurrence.
Good operative candidate as determined by the treating physician and/or multidisciplinary team.
Subject capable of giving informed consent and participating in the process of consent.
Disqualifiers
Pregnant or breastfeeding, or expecting to conceive within the projected duration of the study.
they are menopausal defined by not having a menstrual cycle within the last 12 consecutive months or
they have had a hysterectomy.
Known allergy to iodides or shellfish.
Trial design
Treatments tested in this trial
- Indocyanine Green (ICG)
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov